
ADAR1 CAPITAL MANAGEMENT, LLC
Latest 13F filing data - Q1 2026
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | IKT | 6.61M | $11.10M |
![]() | OVID | 4.54M | $10.09M |
![]() | IVVD | 3.82M | $4.97M |
![]() | AVR | 3.79M | $21.03M |
![]() | EQ | 3.73M | $7.45M |
![]() | CTMX | 3.41M | $16.03M |
![]() | ROIV | 3.29M | $91.02M |
![]() | ABUS | 3.13M | $14.10M |
![]() | TSHA | 2.98M | $13.32M |
![]() | VIR | 2.74M | $24.59M |
![]() | IMVT | 2.68M | $66.55M |
![]() | PLRX | 2.59M | $3.26M |
![]() | OKUR | 2.43M | $10.08M |
![]() | PALI | 2.26M | $3.96M |
![]() | IVA | 2.17M | $12.07M |
![]() | ABOS | 2.16M | $5.09M |
![]() | PRME | 1.97M | $6.87M |
![]() | DNLI | 1.87M | $35.93M |
![]() | PEPG | 1.61M | $2.85M |
![]() | REPL | 1.58M | $12.11M |

Inhibikase Therapeutics, Inc.
IKT
Shares Held
6.61M
Value
$11.10M

Ovid Therapeutics Inc.
OVID
Shares Held
4.54M
Value
$10.09M

Invivyd, Inc.
IVVD
Shares Held
3.82M
Value
$4.97M

Anteris Technologies Global Corp.
AVR
Shares Held
3.79M
Value
$21.03M

Equillium, Inc.
EQ
Shares Held
3.73M
Value
$7.45M

CytomX Therapeutics, Inc.
CTMX
Shares Held
3.41M
Value
$16.03M

Roivant Sciences Ltd.
ROIV
Shares Held
3.29M
Value
$91.02M

Arbutus Biopharma Corporation
ABUS
Shares Held
3.13M
Value
$14.10M

Taysha Gene Therapies, Inc.
TSHA
Shares Held
2.98M
Value
$13.32M

Vir Biotechnology, Inc.
VIR
Shares Held
2.74M
Value
$24.59M

Immunovant, Inc.
IMVT
Shares Held
2.68M
Value
$66.55M

Pliant Therapeutics, Inc.
PLRX
Shares Held
2.59M
Value
$3.26M

OnKure Therapeutics, Inc.
OKUR
Shares Held
2.43M
Value
$10.08M

Palisade Bio, Inc.
PALI
Shares Held
2.26M
Value
$3.96M

Inventiva S.A.
IVA
Shares Held
2.17M
Value
$12.07M

Acumen Pharmaceuticals, Inc.
ABOS
Shares Held
2.16M
Value
$5.09M

Prime Medicine, Inc.
PRME
Shares Held
1.97M
Value
$6.87M

Denali Therapeutics Inc.
DNLI
Shares Held
1.87M
Value
$35.93M

PepGen Inc.
PEPG
Shares Held
1.61M
Value
$2.85M

Replimune Group, Inc.
REPL
Shares Held
1.58M
Value
$12.11M
